Skip to content

A Study on the Efficacy and Safety of Transvaginal Microwave Therapy Combined with Electrical Stimulation in the Treatment of Myofascial Pelvic Pain Syndrome

A Study on the Efficacy and Safety of Transvaginal Microwave Therapy Combined with Electrical Stimulation in the Treatment of Myofascial Pelvic Pain Syndrome

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500108028
Enrollment
Unknown
Registered
2025-08-22
Start date
2025-09-01
Completion date
Unknown
Last updated
2025-08-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myofascial Pelvic Pain Syndrome, MPPS

Interventions

Treatment Group (ES + Active MT):Transvaginal Electrical Stimulation Combined with Microwave Therapy
Control Group (ES + Sham MT):Transvaginal Electrical Stimulation Combined with Sham Microwave Therapy

Sponsors

Jiaxing University Affiliated Women and Children Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. Women aged 18-65 years; 2. Meet the clinical diagnostic criteria for MPPS, and have one or more MTrPs (clear muscle tender points, palpable tension bands or contractile nodules at muscle pain points, trigger points with characteristic referred pain, and rapid tactile pressure can trigger local convulsive reactions); 3. Lochia is clean, no active vaginal bleeding; 4. Understand the content of the study and voluntarily sign the written informed consent form; 5. Receiving and cooperating with transvaginal electrical stimulation and microwave therapy (or sham treatment); 6. Agree to follow the study protocol requirements.

Exclusion criteria

Exclusion criteria: 1. Active pelvic infection (vaginitis, cervicitis, pelvic inflammatory disease, etc.); 2. History or suspected pelvic or genitourinary malignancy; 3. Pregnancy or planning to become pregnant during the study; 4. Pelvic pain caused by other unstable diseases (such as active endometriosis); 5. Presence of metal implants or other conditions in the pelvic area that contraindicate electrical stimulation or microwave therapy (e.g., pacemaker); 6. Presence of psychiatric illness or cognitive impairment that significantly affects study compliance or outcome assessments.

Design outcomes

Primary

MeasureTime frame
Visual Analog Scale (VAS) for pain induced by palpation of myofascial trigger points (MTrPs);Number of myofascial trigger points (MTrPs);Surface electromyography (sEMG) Glazer assessment of pelvic floor muscles;

Secondary

MeasureTime frame
Female Sexual Function Index (FSFI);Pelvic Floor Distress Inventory Short Form (PFDI-20);Pelvic Floor Impact Questionnaire Short Form (PFIQ-7);Patient Global Impression of Change (PGIC);

Countries

China

Contacts

Public ContactJin Wang

Jiaxing University Affiliated Women and Children Hospital

xzwangjin0516@126.com+86 139 5736 7450

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026